Pharmafile Logo
Pharmafocus logo
Advanced Search
age

Diabetes drugs show potential in treating Alzheimer’s

January 3, 2018
Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical

A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has …

News
epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018
Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …

News
Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018
Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …

News
dermapace-product

FDA approves shock wave wound healing device

January 2, 2018
Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …

News
mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018
Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …

News
valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018
Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten stories of 2017

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Actelion, Amgen, AstraZeneca, Cyber attack, EMA, European Commission, Humira, J&J, JJ, Johnson & Johnson, MSD, Sanofi, Shire, Teva, biosimilar, brexit

After a packed year that has flown by, we’ve reached the final top ten of 2017. Below you can find …

News
2018

Seven pharma trends for 2018

December 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …

Feature
fda2outsideweb

La Jolla Pharmaceutical scores FDA approval for blood pressure treatment

December 22, 2017
Medical Communications, Sales and Marketing FDA, La Jolla pharmaceutical, blood pressure, pharma

The FDA has announced that it has approved La Jolla Pharmaceutical’s Giapreza (angiotensin II) injection for intravenous infusion to increase …

News

Novartis hit by court loss, could spur numerous cases across industry

December 22, 2017
Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …

News

Roche boosts oncology portfolio with $1.7bn acquisition

December 22, 2017
Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical

Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …

News
nerve-cell-2213009_960_720

Eisai and Biogen Alzheimer’s drug stumbles at P2

December 21, 2017
Medical Communications, Research and Development Biogen, Eisai, biotech, drugs, pharma, pharmaceutical

Only a few months ago, it was announced that Eisai had decided to opt into the development process of BAN2401. …

News
shutterstock_360472550

Higher mutational burdens in tumours linked to greater immunotherapy success, study finds

December 21, 2017
Research and Development Cancer, Johns Hopkins Kimmel Cancer Center, checkpoint inhibitors, mutational burden, pharma

New research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Cancer Institute for Cancer Immunotherapy has indicated that …

News
roche

FDA grants breast cancer approval to Roche’s Perjeta/Herceptin combo therapy

December 21, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche has announced that the FDA has granted approval to Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and a (Perjeta-based) …

News
attribution-icon-2888829_640

The rare disease climate in Europe

December 21, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …

Feature

Pfizer’s Bosulif scores US green light in leukaemia sub-type

December 21, 2017
Sales and Marketing FDA, Pfizer, bosulif, leukaemia, leukemia, pharma

Pfizer has revealed that its tyrosine kinase inhibitor Bosulif (bosutinib) has been awarded marketing authorisation from the FDA in the …

News
merck_and_co

MSD and Pfizer receive approval for combo diabetes therapy

December 21, 2017
Sales and Marketing MSD, Pfizer, biotech, diabetes, drugs, pharma, pharmaceutical

MSD (known as Merck in North America) and Pfizer have announced that their sodium-glucose co-transporter 2 (SGLT2) inhibitor has received …

News
abbvieuse_036_low

Death in trial blackens AbbVie’s positive rheumatoid arthritis data

December 21, 2017
Research and Development AbbVie, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

AbbVie posted strong results from its Phase 3 trial into its treatment for rheumatoid arthritis, upadacitinib, but discussions of the …

News

J&J struck by €25m fine over fentanyl pain patch

December 20, 2017
Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, fentanyl, pharma, pharmaceutical

Johnson & Johnson has been fined by France’s competition authority, Autorité de la Concurrence, after it alleges the company had …

News
genentechlr

Genentech seals deal with DiCE Molecules

December 20, 2017
Research and Development, Sales and Marketing DiCE, Genentech, Sanofi, biotech, drugs, pharma, pharmaceutical

Genentech has followed in the footsteps of its parent company by signing a drug discovery agreement with DiCE Molecules. The …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026